Vantage Investment Advisors, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Vantage Investment Advisors, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2018$10,000
-16.7%
1000.0%0.00%
-33.3%
Q2 2018$12,000
+20.0%
1000.0%0.00%0.0%
Q1 2018$10,0000.0%1000.0%0.00%
+50.0%
Q4 2017$10,000
-9.1%
1000.0%0.00%
-33.3%
Q3 2017$11,0000.0%1000.0%0.00%0.0%
Q2 2017$11,000
-8.3%
1000.0%0.00%
-25.0%
Q1 2017$12,000
+9.1%
1000.0%0.00%0.0%
Q4 2016$11,0000.0%1000.0%0.00%
-20.0%
Q3 2016$11,000
-26.7%
1000.0%0.01%
-16.7%
Q2 2016$15,0001000.01%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Claret Asset Management Corp 86,474$6,524,0001.34%
Analyst IMS Investment Management Services Ltd. 28,438$2,143,0000.64%
ALGERT GLOBAL LLC 20,876$1,575,0000.59%
Quantinno Capital Management LP 9,351$706,0000.48%
Crestline Management, LP 37,000$2,792,0000.45%
Empirical Finance, LLC 9,561$721,0000.20%
BRANDES INVESTMENT PARTNERS, LP 55,065$5,469,0000.14%
FORT, L.P. 9,672$730,0000.14%
CAXTON ASSOCIATES LP 8,865$669,0000.13%
ACADIAN ASSET MANAGEMENT LLC 330,448$24,928,0000.11%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders